Asset Dedication LLC’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.58M | Sell |
3,816
-257
| -6% | -$263K | 0.29% | 59 |
|
|
2026
Q1 | $3.75M | Sell |
4,073
-263
| -6% | -$267K | 0.26% | 62 |
|
|
2025
Q4 | $4.66M | Buy |
4,336
+4
| +0.1% | +$3.83K | 0.31% | 51 |
|
|
2025
Q3 | $3.31M | Sell |
4,332
-408
| -9% | -$304K | 0.22% | 65 |
|
|
2025
Q2 | $3.7M | Buy |
4,740
+234
| +5% | +$182K | 0.27% | 56 |
|
|
2025
Q1 | $3.72M | Sell |
4,506
-544
| -11% | -$453K | 0.3% | 56 |
|
|
2024
Q4 | $3.9M | Sell |
5,050
-2,215
| -30% | -$1.83M | 0.31% | 52 |
|
|
2024
Q3 | $6.44M | Sell |
7,265
-1,428
| -16% | -$1.28M | 0.43% | 47 |
|
|
2024
Q2 | $7.87M | Buy |
8,693
+351
| +4% | +$281K | 0.55% | 37 |
|
|
2024
Q1 | $6.49M | Sell |
8,342
-1,015
| -11% | -$722K | 0.48% | 44 |
|
|
2023
Q4 | $5.44M | Buy |
9,357
+901
| +11% | +$526K | 0.44% | 49 |
|
|
2023
Q3 | $4.57M | Buy |
8,456
+166
| +2% | +$85.5K | 0.39% | 56 |
|
|
2023
Q2 | $3.86M | Buy |
8,290
+680
| +9% | +$285K | 0.33% | 61 |
|
|
2023
Q1 | $2.61M | Buy |
7,610
+5,045
| +197% | +$1.7M | 0.24% | 84 |
|
|
2022
Q4 | $944K | Buy |
2,565
+629
| +32% | +$223K | 0.1% | 167 |
|
|
2022
Q3 | $625K | Buy |
+1,936
| New | +$613K | 0.07% | 189 |
|
|
2022
Q2 | – | Sell |
-1,674
| Closed | -$480K | – | 768 |
|
|
2022
Q1 | $480K | Sell |
1,674
-209
| -11% | -$53.8K | 0.05% | 214 |
|
|
2021
Q4 | $519K | Buy |
1,883
+271
| +17% | +$68.7K | 0.06% | 192 |
|
|
2021
Q3 | $373K | Buy |
1,612
+214
| +15% | +$52.8K | 0.05% | 213 |
|
|
2021
Q2 | $322K | Buy |
1,398
+169
| +14% | +$33.9K | 0.05% | 220 |
|
|
2021
Q1 | $228K | Sell |
1,229
-361
| -23% | -$70.6K | 0.05% | 206 |
|
|
2020
Q4 | $267K | Sell |
1,590
-37
| -2% | -$5.52K | 0.05% | 209 |
|
|
2020
Q3 | $241K | Buy |
1,627
+206
| +14% | +$31.9K | 0.05% | 204 |
|
|
2020
Q2 | $233K | Sell |
1,421
-114
| -7% | -$17.5K | 0.06% | 187 |
|
|
2020
Q1 | $215K | Buy |
1,535
+681
| +80% | +$93.6K | 0.06% | 186 |
|
|
2019
Q4 | $112K | Buy |
854
+400
| +88% | +$46.4K | 0.03% | 228 |
|
|
2019
Q3 | $52K | Buy |
454
+358
| +373% | +$39.9K | 0.02% | 280 |
|
|
2019
Q2 | $11K | Sell |
96
-400
| -81% | -$47.1K | ﹤0.01% | 419 |
|
|
2019
Q1 | $64K | Sell |
496
-16
| -3% | -$1.95K | 0.02% | 256 |
|
|
2018
Q4 | $59K | Hold |
512
| – | – | 0.02% | 249 |
|
|
2018
Q3 | $55K | Hold |
512
| – | – | 0.02% | 254 |
|
|
2018
Q2 | $44K | Hold |
512
| – | – | 0.02% | 281 |
|
|
2018
Q1 | $40K | Buy |
512
+321
| +168% | +$25.8K | 0.02% | 252 |
|
|
2017
Q4 | $16K | Hold |
191
| – | – | 0.01% | 328 |
|
|
2017
Q3 | $17K | Hold |
191
| – | – | 0.01% | 272 |
|
|
2017
Q2 | $16K | Sell |
191
-38
| -17% | -$3.1K | 0.01% | 277 |
|
|
2017
Q1 | $20K | Buy |
229
+150
| +190% | +$12K | 0.01% | 260 |
|
|
2016
Q4 | $6K | Hold |
79
| – | – | ﹤0.01% | 330 |
|
|
2016
Q3 | $6K | Hold |
79
| – | – | ﹤0.01% | 327 |
|
|
2016
Q2 | $6K | Sell |
79
-509
| -87% | -$38.3K | ﹤0.01% | 306 |
|
|
2016
Q1 | $42K | Buy |
588
+197
| +50% | +$14.9K | 0.03% | 196 |
|
|
2015
Q4 | $33K | Buy |
+391
| New | +$32.4K | 0.02% | 269 |
|
Other funds holding LLY
Asset Dedication LLC's LLY Position: Q2 2026 in Review
Asset Dedication LLC reduced its Eli Lilly (LLY) stake by 6.3% in Q2 2026, selling an estimated $263K and leaving 3,816 shares worth $4.58M. The position accounts for 0.29% of the portfolio, ranked #59.
Asset Dedication LLC first reported a position in LLY in Q4 2015 and has held it in 42 quarters since. The position peaked at $7.87M in Q2 2024. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Asset Dedication LLC held 3,816 shares of Eli Lilly worth $4.58M as of Q2 2026.
- Asset Dedication LLC sold 257 Eli Lilly shares in Q2 2026, an estimated $263K.
- Eli Lilly made up 0.29% of Asset Dedication LLC's portfolio in Q2 2026, its #59 holding.
- Asset Dedication LLC first reported a position in Eli Lilly in Q4 2015 and has held it in 42 quarters since.
- Asset Dedication LLC's Eli Lilly position peaked at $7.87M in Q2 2024.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.